by Harold W. Manner, Ph.D. Metabolic Research
Foundation in collaboration with Manner Memorial
Hospital and Cyto Pharma de Mexico, S.A
Metabolic Therapy in Cancer
Introduction
In recent years, a significant reassessment of the
nature and causes of cancer has taken place. Cancer
was formerly believed to be a localised disease,
characterised by a lesion, usually in the form of a
growth, which appeared at some specific part of the
body. This localised lesion was thought to be the
result of activity produced by an invading virus,
carcinogenic agent or some form of trauma such as a
shock.
Today, there is a growing conviction among
researchers and physicians that cancer is a complex
disease that is the end result of a disturbed
metabolism (body chemistry).
Cancer is an insidious disease that involves the
entire body; the nervous system, digestive tract,
pancreas, lungs, excretory organs, endocrine system,
and the entire defence mechanism of the body. The
frequent reoccurrence of a malignancy after
treatment with the conventional methods of surgery,
radiation and/or chemotherapy results because the
basic underlying metabolic cause of the cancer is
rarely considered and, as a consequence, remains
uncorrected.
Cancer Aetiology
In the human body there are many thousands of cells
that are arrested, during development, at an
embryonic stage. These cells are called mesenchymal
cells, fibroblasts, neoblasts, etc. Their primary
function is repair. When a bone is broken, these
cells are able to transform into bone cells. If
blood is lost, these same cells are able to
transform into blood cells. They are truly
pluripotential and can react to any number of
morphogenetic stimuli. These same cells, when
subjected to carcinogens (cancer-causing chemicals)
develop into cancer cells.
Each day, in every human being, large numbers of
these normal embryonic cells become cancerous. They
rarely, however, become the diseases that we call
cancer due to a remarkable system called the immune
system. The function of this system is to destroy
or neutralise all foreign material in the body. Once
an embryonic cell becomes a cancer cell it becomes,
from a biochemical point of view, foreign to the
body. We, therefore, continue to remain healthy
because the lymphocytes, macrophages, and other
components of the immune system are able to
neutralise or destroy these cells and prevent their
spreading and multiplication. These cancer cells
are normally destroyed by our body's defence
mechanisms within a few hours.
If the immune system, however, is weakened because
of poor nutrition, excessive environmental
pollutants or continuing debilitating stress, the
cancer cells are uninhibited and will multiply
rapidly forming the symptomatic "growth" of cancer.
Our immune system generally weakens with advancing
age. This increases the possibility of degenerative
metabolic diseases occurring. One of the primary
objectives of all metabolic therapy is to revitalise
the body's immune system and to restore it to a
fully functional condition. Accomplishment of this
goal permits the immune system to eliminate or
otherwise negate the cancer cells before they can
begin an invasive growth.
Metabolic physicians and researchers believe that we
can remain healthy if we supply the individual cells
of the body with the proper amounts of oxygen,
nutrients, enzymes, minerals, amino acids, and other
essential nutrients that we can provide both our
diet and nutritional supplements. Of equal
importance is the ability of the body to eliminate
the waste products of cellular metabolism through
proper bowel movements, efficient breathing, normal
excretion, etc. Treatments must also be provided
which will help the body detoxify itself by
eliminating harmful pollutants.
This, in essence, is the central thought of
metabolic therapy. It is a multi-faceted programme,
incorporating numerous related elements, each of
which plays an important role in the success of the
complete therapy.
fj. Philip Brinzel M. D.
Laetrile and the Life Saving Substance Called
Cyanide
A doctor from the FDA once said that Laetrile
contains "free" hydrogen cyanide and, thus, is
toxic. I would like to correct that misconception:
There is no "free" hydrogen cyanide in Laetrile.
When Laetrile comes in contact with the enzyme beta-glucosidase,
the Laetrile is broken down to form two molecules of
glucose, one molecule of benzaldehyde and one
molecule of hydrogen cyanide (HCN). Within the body,
the cancer cell – and only the cancer cell –
contains that enzyme in significant quantities.
The key word here is that the HCN must be FORMED.
This substance is not floating around freely in the
Laetrile and then released. It must be manufactured.
The enzyme beta glucosidase, and only that enzyme,
is capable of manufacturing the HCN from Laetrile.
If there are no cancer cells in the body, there is
no beta-glucosidase. If there is no beta-glucosidase,
no HCN will be formed from the Laetrile (1).
Laetrile does contain a cyanide radical (CN). This
same cyanide radical is contained in Vitamin B12,
and in forest fruits such as blackberries,
blueberries and strawberries. You never hear of
anyone getting cyanide poisoning from B12 or any of
the above-mentioned forest fruits, because there’s
no such thing. The cyanide radical (CN) and
hydrogen cyanide (HCN) are two completely different
compounds, just as pure sodium (Na+) – one of the
most toxic substances known to mankind – and sodium
chloride (NaCl), which is table salt, are two
completely different compounds.
1 For a more detailed analysis of the
theoretical action of Laetrile against cancer cells,
see the book of G. Edward Griffin, World Without
Cancer.
If the above is true, how did the story ever get
started that Laetrile contains "free" hydrogen
cyanide?
It was the Food and Drug Administration. I remember
reading in some newspaper back in the late 1960s or
early 1970s a news release from the FDA. This
release stated that there were some proponents of a
substance known as "Laetrile" (I'd never heard of it
before) who were saying that this substance was
capable of forming hydrogen cyanide in the presence
of the cancer cell. The release continued by saying
that, if this were actually true, we had, indeed,
found a substance, which was target-specific, and
would be of great value to the cancer patient. But,
the news release went on to say, the FDA had done
extensive testing of this substance, "Laetrile," and
found no evidence that it contained hydrogen cyanide
or that any hydrogen cyanide was released in the
presence of the cancer cell. Thus, they reached the
conclusion that Laetrile was of no value.
When it was clearly established some time later that
Laetrile did, indeed, release hydrogen cyanide in
the presence of the cancer cell, how do you suppose
the FDA reacted? Did they admit that they were
wrong? Did they admit that they had done a very
inadequate job in running their tests? No! They now
proclaimed that Laetrile contained hydrogen cyanide
and thus was toxic!
So, here is a bureau of the Federal Government
which, a short time before, had said that the reason
Laetrile did not work was because it did not release
hydrogen cyanide in the presence of cancer cells.
Now, when they find that it does, they say that it
is toxic. When we offered them an opportunity to
present evidence of Laetrile's toxicity in Federal
Court, they admitted that they had none.
B-17 molecule is unbreakable in nature except by the
enzyme glucosidase . There is 3000 times as much
glucosidase in the cancer cell as there is in a
normal cell.
Though it has limitations in certain cancers,
vitamin B-17 may be extremely effective in the most
common tumours such as carcinoma of the lung,
breast, prostate, colon, and lymphomas. A highly
publicised clinical trial conducted by the National
Cancer Institute in 1981 tried unsuccessfully to
prove Laetrile ineffective and toxic. Today,
Laetrile occupies a position on the "front lines" of
alternative cancer therapy. "We have found Laetrile
to be effective in people that have active cancer",
says Dr. Contreras "but that is not its only
function, for the prevention of cancer and the
maintenance of remission there is nothing as
effective as Laetrile. Its non-toxicity permits its
use indefinitely in the prevention of relapses and
the prevention of metastases. Surgery, radiation,
and chemotherapy can only be administered for a
limited time, afterward patients are left without
any protection”. This website will teach you how to
begin and continue metabolic therapy at the comfort
of your own home.
Francisco Contreras, M. D.
Oasis of Hope Hospital
The use of Amygdalin (Vitamin B-17) in Metabolic
Cancer Therapy
Amygdalin's Mode of Action
Metabolism is the total function of our body. In
order for our body to function properly, all its
attributes (physical, mental, and spiritual) must
work in harmony.
Total care is the goal of metabolic therapy.
Metabolic therapy elements are utilised in order to
provide our human organism the best environment to
be able to combat disease and regain health.
Metabolic therapy is a non-toxic cancer treatment
based on the use of vitamin B-17, proteolytic
pancreatic enzymes, immuno-stimulants, vitamins and
mineral supplements. Laetrile (vitamin B-17) is the
chief anti-tumour agent.
Laetrile is a natural chemotherapeutic agent found
in over 1,200 plants, particularly in the seeds of
common fruits such as apricots, peaches, plums, and
apples. It is also a diglucoside with cyanide
radical that is highly "bio-accessible." This means
that it penetrates through the cellular membrane
reaching high intra-cellular concentrations easily.
Only this cyanide radical damages cancer cells, and,
over the years, it has been proven that amygdalin is
completely safe and non-toxic.
The normal cells in our organism contain an enzyme
called rhodanese which "neutralises" the amygdalin.
This enzyme does not allow the amygdalin to release
the cyanide.
In this way, amygdalin only serves as glucose to
healthy cells, providing energy. Malignant cells do
not contain this enzyme, however. In the absence of
rhodanese, amygdalin is activated, liberating the
cyanide radical inside the malignant cell,
eventually causing its destruction.
Only cancer cells are destroyed – but normal ones
are not affected. As the amygdalin attacks unhealthy
cells, benzaldehyde is discharged also, being
converted to benzoic acid, with an effect comparable
to that of aspirin, i.e. it contributes greatly to
pain control.
The hundreds of clinical studies conducted by many
competent physicians around the world, including
those directed by Dr. Emesto Contreras Rodriguez at
the Oasis of Hope Hospital in Mexico, give us
complete confidence that there is no danger in using
Laetrile.
|
|